Retrovirus-mediated Expression of Apolipoprotein A-I in the Macrophage Protects against Atherosclerosis in Vivo

This publication has 27 references indexed in Scilit:

• Accelerated atherosclerosis in C57Bl/6 mice transplanted with ApoE-deficient bone marrow
  Atherosclerosis, 2000
• Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma
  Proceedings of the National Academy of Sciences, 1998
• Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
  Proceedings of the National Academy of Sciences, 1997
• Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.
  Journal of Clinical Investigation, 1995
• Prevention of Atherosclerosis in Apolipoprotein E-Deficient Mice by Bone Marrow Transplantation
  Science, 1995
• Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma
  Biochemistry, 1993
• Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
  Proceedings of the National Academy of Sciences, 1991
• High-Density Lipoprotein — The Clinical Implications of Recent Studies
  New England Journal of Medicine, 1989
• LIPOPROTEIN METABOLISM IN THE MACROPHAGE: Implications for Cholesterol Deposition in Atherosclerosis
  Annual Review of Biochemistry, 1983
• Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1982